Altrius Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.25M | Buy |
118,022
+368
| +0.3% | +$25.7K | 1.93% | 19 |
|
|
2025
Q1 | $8.65M | Buy |
117,654
+2,501
| +2% | +$184K | 2.1% | 9 |
|
|
2024
Q4 | $7.54M | Buy |
115,153
+6,363
| +6% | +$417K | 2.03% | 11 |
|
|
2024
Q3 | $8.48M | Sell |
108,790
-3,424
| -3% | -$267K | 2.12% | 9 |
|
|
2024
Q2 | $8.75M | Sell |
112,214
-525
| -0.5% | -$40.9K | 2.3% | 2 |
|
|
2024
Q1 | $7.64M | Buy |
112,739
+13,022
| +13% | +$882K | 1.93% | 15 |
|
|
2023
Q4 | $6.72M | Buy |
99,717
+1,633
| +2% | +$110K | 1.87% | 15 |
|
|
2023
Q3 | $6.64M | Buy |
98,084
+1,226
| +1% | +$83K | 1.97% | 13 |
|
|
2023
Q2 | $6.93M | Sell |
96,858
-305
| -0.3% | -$21.8K | 2.05% | 11 |
|
|
2023
Q1 | $6.74M | Buy |
97,163
+1,804
| +2% | +$125K | 2.06% | 12 |
|
|
2022
Q4 | $6.47M | Buy |
95,359
+1,419
| +2% | +$96.2K | 2.03% | 7 |
|
|
2022
Q3 | $5.15M | Buy |
93,940
+14,149
| +18% | +$776K | 1.96% | 3 |
|
|
2022
Q2 | $5.27M | Buy |
+79,791
| New | +$5.27M | 1.71% | 6 |
|